Inozyme Pharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inozyme Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • Inozyme Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 62.1M shares, a 33.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 62.1M +15.7M +33.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 61.8M +18.1M +41.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 61.8M +21.4M +52.9% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 61.8M +21.4M +52.9% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 46.4M +6.28M +15.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 43.8M +19.9M +83.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 40.4M +16.7M +70.7% Dec 31, 2022 10-K 2024-03-12
Q3 2022 40.4M +16.7M +70.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 40.1M +16.5M +70.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 23.8M +345K +1.47% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 23.7M +284K +1.21% Dec 31, 2021 10-K 2023-03-22
Q3 2021 23.7M +300K +1.28% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 23.6M +22.2M +1653% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 23.5M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 23.4M +22.2M +1841% Dec 31, 2020 10-K 2022-03-15
Q3 2020 23.4M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 1.34M Jun 30, 2020 10-Q 2020-09-03
Q4 2019 1.2M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.